Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Context Therapeutics Inc. | Chief Financial Officer | Stock Option (right to buy) | 160K | Mar 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CNTX | Context Therapeutics Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 22, 2024 | Chief Financial Officer |
CNTX | Context Therapeutics Inc. | Feb 13, 2023 | 1 | $0 | 4 | Feb 14, 2023 | Chief Financial Officer |
CNTX | Context Therapeutics Inc. | Dec 16, 2022 | 1 | $18.5K | 4 | Dec 19, 2022 | Chief Financial Officer |
CNTX | Context Therapeutics Inc. | Aug 17, 2022 | 1 | $27K | 4 | Aug 17, 2022 | Chief Financial Officer |
CNTX | Context Therapeutics Inc. | Feb 25, 2022 | 1 | $0 | 4 | Feb 25, 2022 | Chief Financial Officer |
CNTX | Context Therapeutics Inc. | Nov 1, 2021 | 1 | $0 | 4 | Nov 1, 2021 | Chief Financial Officer |
CNTX | Context Therapeutics Inc. | Nov 1, 2021 | 0 | $0 | 3 | Nov 1, 2021 | Chief Financial Officer |